Abstract

Abstract Background Dengue fever has emerged as a serious threat in Pakistan in the last few years with high morbidity rates and substantial mortality. In the present study, NS2B/NS3 protease from four dengue virus (DENV) serotypes have been targeted using 2350 phytochemicals from various medicinal plants. Material and methods The phytochemicals were subjected to docking against NS2B/NS3 proteases using AutoDock Vina focusing the binding site, and the binding energies were determined to screen the effectively docked phytochemicals. Pharmacological properties were also analyzed for all the phytochemicals using PreADMET web server. Results Binding affinities ranged from −4.0 to –9.8 kcal/mol and a threshold of −9.0 kcal/mol was applied for screening compounds. A total of 18 phytochemicals are screened for passing all evaluation criteria of a drug in which three were for DENV1-NS2B/NS3, five for DENV2-NS2B/NS3, six for DENV3-NS2B/NS3 and four for DENV4-NS2B/NS3. Erycristagallin and Osajin from Erythrina variegate, PapraineA from Fumaria indica and Aloe-Emodin from Aloe vera are the most potent inhibitors of NS2B/NS3 protease from DENV1, DENV2, DENV3 and DENV4, having binding affinities of −9.6 kcal/mol, −9.6 kcal/mol, −9.6 kcal/mol and −9.2 kcal/mol, respectively. Conclusion The effective drug-like properties of all 18 phytochemicals demonstrate the inhibition potential against dengue virus replication in human beings.

Highlights

  • Dengue fever is considered to be a very crucial disease with the diagnostic rate of infections of about 2 million people per year across the world

  • A total of 18 phytochemicals are screened for passing all evaluation criteria of a drug in which three were for DENV1-Nonstructural protein 2B (NS2B)/Non-structural protein 3 (NS3), five for DENV2-NS2B/NS3, six for DENV3-NS2B/NS3 and four for DENV4-NS2B/NS3

  • All the four proteases were docked with the 2350 phytochemicals from various local medicinal plants

Read more

Summary

Introduction

Dengue fever is considered to be a very crucial disease with the diagnostic rate of infections of about 2 million people per year across the world. Five serotypes of dengue virus have been identified which are DENV-1, DENV-2, DENV-3 and DENV-4 and DENV-5 [3] These first four serotypes are closely related in structure, they interact differently with the antibodies, present in the human blood serum. These viruses share a similarity of almost 65% in the genome while there are genetic variations within a single serotype. NS2B/NS3 protease from four dengue virus (DENV) serotypes have been targeted using 2350 phytochemicals from various medicinal plants. Pharmacological properties were analyzed for all the phytochemicals using PreADMET web server

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call